BiotechTube
seqWell

seqWell

Beverly, United States· Est.
seqwell.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

seqWell is a private, revenue-generating company providing innovative NGS library prep kits and platforms to the genomics research market. Its technology centers on a proprietary TnX Transposase and plate-based workflows that dramatically simplify and scale the library preparation process, a key bottleneck in sequencing. The company's products, including ExpressPlex, purePlex, and plexWell kits, are validated by customers in academia, core facilities, and biotech for applications ranging from pathogen surveillance to single-cell analysis. seqWell's value proposition is reducing hands-on time, minimizing errors, and improving data quality through streamlined, automatable protocols.

Genetics & Genomics

Technology Platform

Proprietary next-generation TnX Transposase enabling true multiplexing, tagmentation-based NGS library preparation with integrated auto-normalization and simplified plate-based workflows.

Funding History

1
SeedUndisclosed

Opportunities

The growing demand for high-throughput genomics in research, clinical, and public health settings creates a large market for simplified, scalable library prep.
Expansion into new applications like long-read sequencing and deeper integration with lab automation present significant growth avenues.
The company's proven utility in critical areas like pathogen surveillance provides a stable use case and visibility.

Risk Factors

Faces intense competition from large, established players in the NGS market.
Technological shifts away from short-read sequencing or tagmentation-based methods could disrupt the core business.
Scaling commercial operations and manufacturing to meet global demand poses execution risks for a growing private company.

Competitive Landscape

seqWell competes in the NGS library prep market against giants like Illumina (Nextera), Thermo Fisher Scientific (Ion Torrent), and Qiagen, as well as other specialist firms. Its differentiation is based on workflow simplicity, true multiplexing scalability from the first step, and built-in normalization—features highlighted as superior by customers compared to traditional multi-step kits.

More companies in United States →